Vectura’s Severe Asthma Treatment Fails in Phase III Trial

Vectura’s Severe Asthma Treatment Fails in Phase III Trial

Source: 
BioSpace
snippet: 

Vectura was studying VR475, a drug-device combination consisting of budesonide delivered by Vectura's proprietary nebulizer inhalation system as a treatment for adolescent and adult patients with severe uncontrolled asthma.